Advisory Committee to the Director (ACD), Centers for Disease Control (CDC) and Prevention-Ethics Subcommittee (ES), 4830-4831 [2010-1811]
Download as PDF
<![CDATA[
4830
Federal Register / Vol. 75, No. 19 / Friday, January 29, 2010 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–1931 Filed 1–28–10; 8:45 am]
BILLING CODE 4140–01–P
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–1929 Filed 1–28–10; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cancer Therapy.
Date: February 5, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sharon K. Gubanich, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 435–
1767, gubanics@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Applications in Mechanisms of Emotion,
Stress and Health.
Date: February 8, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Jane A. DoussardRoosevelt, PhD, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
VerDate Nov<24>2008
16:49 Jan 28, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel. Predictors of
Genitourinary Disorders Studies.
Date: February 23, 2010.
Time: 3 p.m. to 3:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Lakshmanan Sankaran,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 755, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, Ls38z@Nih.Gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Small Grant
Program.
Date: March 12, 2010.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Officer, Review Branch,
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8886,
edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Collaborative
Interdisciplinary Team Science.
Date: March 16, 2010.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8886,
edwardsm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–1928 Filed 1–28–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control
(CDC) and Prevention—Ethics
Subcommittee (ES)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Times and Dates:
3 p.m.–4 p.m., February 18, 2010.
8:30 a.m.–12:30 p.m., February 19, 2010.
Place: CDC, Thomas R. Harkin Global
Communication Center, Auditorium B–3,
1600 Clifton Road NE., Atlanta, Georgia
30333. This meeting is also available by
teleconference. Please dial (877) 928–1204
and enter code 4305992.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 60 people. To
accommodate public participation in the
meeting, a conference telephone line will
also be available. The public is welcome to
participate during the public comment
periods. The public comment periods are
tentatively scheduled for 4 p.m.–4:15 p.m. on
E:\FR\FM\29JAN1.SGM
29JAN1
Federal Register / Vol. 75, No. 19 / Friday, January 29, 2010 / Notices
February 18, 2010 and 12 p.m.–12:15
p.m. on February 19, 2010.
Purpose: The ES provides counsel to the
ACD, CDC, regarding a broad range of public
health ethics questions and issues arising
from programs, scientists, and practitioners.
Matter to be Discussed: Agenda items will
include the following topics: status of
ongoing ES activities; review of the CDC
Director’s organizational improvement
activities; review of the Director’s priorities;
and discussion of the future direction for the
ES. The agenda is subject to change as
priorities dictate.
Contact Person for More Information: Drue
Barrett, Ph.D., Designated Federal Officer,
ACD, CDC–ES, 1600 Clifton Road, NE., M/S
D–50, Atlanta, Georgia 30333. Telephone:
(404) 639–4690. E-mail: dbarrett@cdc.gov.
The deadline for notification of attendance is
February 12, 2010.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: January 25, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–1811 Filed 1–28–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodevelopment and Cellular
Metabolism.
Date: February 22–23, 2010.
Time: 7 a.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
16:49 Jan 28, 2010
Jkt 220001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Carol Hamelink, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; ZRG1
DKUS–F 02 M Member Conflict.
Date: February 25, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rass M. Shayiq, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Computational Modeling and Sciences for
Biomedical and Clinical Applications.
Date: March 1, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Guo Feng Xu, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 08–
139: Tools for Zebrafish Research.
Date: March 1, 2010.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Latham Hotel, 3000 M Street, NW.,
Washington, DC 20007.
Contact Person: Cathy Wedeen, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3213,
MSC 7808, Bethesda, MD 20892, 301–435–
1191, wedeenc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: B cell Regulation and Tolerance to
Cancer Antigens.
Date: March 1, 2010.
Time: 8:30 a.m. to 9:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Bahiru Gametchu, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1225, gametchb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
F07 Immunology Fellowship AREA.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
4831
Date: March 1–2, 2010.
Time: 9:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Hayden, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, 301–435–
1223, haydenb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 08–
138: Zebrafish Screens.
Date: March 1, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Latham Hotel, 3000 M Street, NW.,
Washington, DC 20007.
Contact Person: John Burch, PhD,
Scientific Review Officer, National Institute
of Health, Center for Scientific Review, 6701
Rockledge Drive, Room 3213, MSC 7808,
Bethesda, MD 20892, 301–435–1019,
burchjb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Electrical Signaling and Cardiac
Function.
Date: March 2, 2010.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Maqsood A. Wani, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114,
MSC 7814, Bethesda, MD 20892, 301–435–
2270. wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Molecular
Biology.
Date: March 2, 2010.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Diane L. Stassi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
MSC 7890, Bethesda, MD 20892, 301–435–
2514, stassid@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Physiology and Pathobiology of
Cardiovascular and Respiratory Systems
(F10A).
Date: March 3–4, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Abdelouahab Aitouche,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 75, Number 19 (Friday, January 29, 2010)]
[Notices]
[Pages 4830-4831]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1811]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control (CDC) and Prevention--Ethics Subcommittee (ES)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Times and Dates:
3 p.m.-4 p.m., February 18, 2010.
8:30 a.m.-12:30 p.m., February 19, 2010.
Place: CDC, Thomas R. Harkin Global Communication Center,
Auditorium B-3, 1600 Clifton Road NE., Atlanta, Georgia 30333. This
meeting is also available by teleconference. Please dial (877) 928-
1204 and enter code 4305992.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people. To
accommodate public participation in the meeting, a conference
telephone line will also be available. The public is welcome to
participate during the public comment periods. The public comment
periods are tentatively scheduled for 4 p.m.-4:15 p.m. on
[[Page 4831]]
February 18, 2010 and 12 p.m.-12:15 p.m. on February 19, 2010.
Purpose: The ES provides counsel to the ACD, CDC, regarding a
broad range of public health ethics questions and issues arising
from programs, scientists, and practitioners.
Matter to be Discussed: Agenda items will include the following
topics: status of ongoing ES activities; review of the CDC
Director's organizational improvement activities; review of the
Director's priorities; and discussion of the future direction for
the ES. The agenda is subject to change as priorities dictate.
Contact Person for More Information: Drue Barrett, Ph.D.,
Designated Federal Officer, ACD, CDC-ES, 1600 Clifton Road, NE., M/S
D-50, Atlanta, Georgia 30333. Telephone: (404) 639-4690. E-mail:
dbarrett@cdc.gov. The deadline for notification of attendance is
February 12, 2010.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: January 25, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-1811 Filed 1-28-10; 8:45 am]
BILLING CODE 4163-18-P
